Home > Healthcare & Medical Devices > U.S. Clinical Nutrition Market

U.S. Clinical Nutrition Market - By Product (Infant Nutrition, Enteral Nutrition, Parenteral Nutrition), By Consumer (Pediatric, Adult), By Application (Metabolic Disorders, Neurological Diseases), Distribution Channel, Dosage Formulation & Forecast, 2023 - 2032

  • Report ID: GMI4514
  • Published Date: May 2023
  • Report Format: PDF

U.S. Clinical Nutrition Market Size

U.S. Clinical Nutrition Market size was over USD 12 billion in 2022 and will grow at over 9% CAGR from 2023 to 2032, driven by the increasing incidence of chronic diseases and metabolic diseases in the U.S.


U.S. Clinical Nutrition Market

To understand key trends  
Download Free Sample

Surging prevalence of non-communicable and chronic diseases such as type 2 diabetes, cardiovascular disorders, obesity, and others that require prolonged hospitalization has increased awareness of clinical nutrition in the U.S. As per the Sudden Cardiac Arrest Foundation, out-of-hospital cardiac arrests affect over 356,000 people every year in the U.S., of which 90% are fatal.


Growing government investments to improve nutrition security in the country are further expected to bolster the industry outlook. For instance, in November 2022, the USDA announced an investment of around USD 59.4 million to improve dietary health and nutrition security in the country.


Despite such an optimistic scenario, tightening government norms related to clinical nutrition products may pose challenges to industry expansion. The U.S. FDA regulates clinical nutrition products under a different set of regulations than those of traditional food and drug products. As per the Dietary Supplement Health and Education Act of 1994, the marketing of misbranded clinical nutrition products is strictly prohibited. Additionally, FDA holds the authority to take action against such products after they reach the market.


U.S. Clinical Nutrition Market Analysis

U.S. Clinical Nutrition Market Size, By Product

To understand key market trends  
Download Free Sample

U.S. infant clinical nutrition market size was over USD 6.5 billion in 2022. Increasing instances of premature births have increased the demand for infant nutrition products in the U.S. As per the CDC, in 2021, premature births affected 1 in every 10 infants in the country. The administration of clinical nutrition products in infants is known to offer metabolic and immunogenic support to prevent the risk of growth incapacities and abnormalities. Growing concerns related to infant nutrition have increased the demand for clinical nutrition products in the U.S.


U.S. Clinical Nutrition Market Share, By Application

To understand key market trends  
Download Free Sample

U.S. clinical nutrition market size from metabolic disorders applications will be over USD 9 billion by 2032. Growing occurrence of metabolic disorders such as heart disease, type 2 diabetes, and others has increased the need for nutritional support in the country.  Moreover, growing demand and awareness regarding the benefits offered by disease-specific clinical nutrition products in the precise management of various metabolic conditions is further working in favor of segment expansion.

U.S. Clinical Nutrition Market Share

  • Meiji Holdings Co Ltd.
  • Abbott Laboratories
  • Mead Johnson (Rickett Benckiser)
  • Pfizer Inc.
  • Fresenius Kabi AG
  • Nestle Health Science S.A.
  • Grifols SA

U.S. clinical nutrition market news:

  • November 2021 - Abbott Laboratories, an American multinational healthcare company, launched Similac 360 Total Care, which is an exclusive blend of five HMO prebiotics to support the digestive health, immune system, and brain development of infants. This launch helped the company broaden its product portfolio while maximizing revenue.
  • June 2021 - Vitaflo International, a division of Nestlé Health Science acquired the manufacturing plant and some brands of Dr. Schär, including ComidaMed and Mevalia. The acquisition enabled the company to boost its offerings in the infant nutrition sector.

U.S. clinical nutrition market report includes in-depth coverage of the industry with estimates & forecast in terms of revenue in USD million from 2018 to 2032 for the following segments:

Click here to Buy Section of this Report

Market Size, By Product

  • Infant Nutrition
    • Milk Based
    • Soy Based
    • Organic Formulas
    • Others
  • Enteral Nutrition
    • Standard Composition
    • Disease Specific Composition
  • Parenteral Nutrition
    • Amino Acids
    • Fats
    • Carbohydrates
    • Others

Market Size, By Consumer

  • Pediatric
  • Adult

Market Size, By Application

  • Cancer
  • Metabolic Disorders
  • Neurological Diseases
  • Gastrointestinal Disorders
  • Others

Market Size, By Distribution Channel

  • Retail Stores
  • Pharmacies & Drug Stores
  • Online Channels
  • Others

Market Size, By Dosage Formulation

  • Powder
  • Liquid
  • Solid



Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

U.S. market in clinical nutrition was USD 12 billion and will grow at over 9% CAGR from 2023 to 2032, driven by surging incidence of metabolic and chronic disorders in the country.

U.S. infant nutrition industry size was more than USD 6.5 billion in 2022, on account of rising prevalence of pre-term births in the country.

Some of the leading U.S. clinical nutrition market players are Mead Johnson (Reckitt Benckiser), Danone, Hero Nutritionals Inc, Pfizer, Inc., Aculife Healthcare Pvt Ltd, and Nestle Health Science, among others.

U.S. Clinical Nutrition Market Scope

Buy Now

Access to only 1 person; cannot be shared; cannot be printed
Access for 2 to 5 users only within same department of one company
Access to a company wide audience; includes subsidiary companies or other companies within a group of companies

Premium Report Details

  • Base Year: 2022
  • Companies covered: 15
  • Tables & Figures: 79
  • Countries covered: 1
  • Pages: 90
 Download Free Sample